These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 805659)

  • 1. A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms.
    van Nagell JR; Pletsch QA; Goldenberg DM
    Cancer Res; 1975 Jun; 35(6):1433-7. PubMed ID: 805659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the carcinoembryonic antigen activity associated with cyst fluids of mucinous ovarian cystadenocarcinoma.
    Yamashita K; Aitio ML; Dawson JR
    Cancer Res; 1979 May; 39(5):1760-5. PubMed ID: 85489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA 125 and carcinoembryonic antigen levels in cyst fluid, ascites and serum of patients with ovarian neoplasms.
    Harłozińska A; Bar JK; Gawlikowski W; Richter R; Cisło M
    Ann Chir Gynaecol; 1991; 80(4):368-75. PubMed ID: 1667567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and immunohistochemical studies on carcinoembryonic antigen of ovarian mucinous and serous tumors.
    Tohya T; Iwamasa T; Maeyama M
    Gynecol Oncol; 1986 Mar; 23(3):291-303. PubMed ID: 3514390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen in human ovarian neoplasms.
    Marchand A; Fenoglio CM; Pascal R; Richart RM; Bennett S
    Cancer Res; 1975 Dec; 35(12):3807-10. PubMed ID: 1192434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CEA determination in aspired fluid of cystic ovarian tumors and ovarian cysts and in ascites and serum samples of patients with ovarian tumors].
    Kunze M; Büttner HH; Strache RR; Voss P; Briese V; Schrodt U
    Zentralbl Gynakol; 1988; 110(16):1006-12. PubMed ID: 3188713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma carcinoembryonic antigen levels in ovarian cancer patients: a chart review and survey of published data.
    Stall KE; Martin EW
    J Reprod Med; 1981 Feb; 26(2):73-9. PubMed ID: 7012337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic biliary cystadenoma: role of cyst fluid analysis and surgical management in the laparoscopic era.
    Koffron A; Rao S; Ferrario M; Abecassis M
    Surgery; 2004 Oct; 136(4):926-36. PubMed ID: 15467680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
    Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
    Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
    Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
    JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor and serum CEA content in gynecologic neoplasms.
    Kula J; Richter R; Gawlikowski W; Harłozińska A
    Neoplasma; 1984; 31(1):89-93. PubMed ID: 6322027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated antigen for cystadenocarcinomas of the ovary.
    Bhattacharya M; Barlow JJ
    Natl Cancer Inst Monogr; 1975 Oct; 42():25-32. PubMed ID: 825781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucinous cystic neoplasm of the pancreas with high carcinoembryonic antigen.
    Yu HC; Shetty J
    Arch Pathol Lab Med; 1985 Apr; 109(4):375-7. PubMed ID: 3885900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Density distribution and antigenic characterization of cell subpopulations isolated from cystic fluids of ovarian serous neoplasms.
    Harłozińska A; Bar JK; Rabczyński J; Noworolska A; Richter R; Cisło M
    Anticancer Res; 1989; 9(1):161-6. PubMed ID: 2705745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated antigen CA 195 in patients with mucinous ovarian tumours: a comparative analysis with CEA, TATI and CA 125 in serum specimens and cyst fluids.
    de Bruijn HW; ten Hoor KA; Boonstra H; Marrink J; Krans M; Aalders JG
    Tumour Biol; 1993; 14(2):105-15. PubMed ID: 8392219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas.
    Tatsuta M; Iishi H; Ichii M; Noguchi S; Yamamoto R; Yamamura H; Okuda S
    Cancer; 1986 May; 57(9):1836-9. PubMed ID: 2420441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
    Ayhan A; Guven S; Guven ES; Kucukali T
    Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cystic fluid in diagnosis of the pancreatic cystadenoma and cystadenocarcinoma.
    Wu H; Yan LN; Cheng NS; Zhang YG; Ker CG
    Hepatogastroenterology; 2007; 54(79):1915-8. PubMed ID: 18251127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor associated antigen in ovarian carcinoma.
    Negishi Y; Mutai Y; Akiya K; Fujiwara Y; Singh G
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):126-32. PubMed ID: 6199439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.